Anxiolytic-like effect of trans-2-decenoic acid ethyl ester in stress-induced anxiety-like model mice

Biomedical Research (Japan)

Volumn 34, Issue 5, 2013, Pages 259-267

  Makino, Akihisa ^a   Iinuma, Munekazu ^a   Fukumitsu, Hidefumi ^a   Soumiya, Hitomi ^a   Furukawa, Yoshiko ^b   Furukawa, Shoei ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b MATSUYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FLUVOXAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN 3; TRANS 2 DECENOIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DRUG STRUCTURE; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTORS; PHOSPHORYLATION; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84887101700     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.259     Document Type: Article

References (33)

1. Anacker C, Zunszain PA, Cattaneo A, Carvalho LA, Garabedian MJ, Thuret S, Price J and Pariante CM (2011) Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 16, 738-750.
2. Andero R, Heldt SA, Ye K, Liu X, Armario A and Ressler KJ (2011) Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry 168, 163-172.
3. Andero R and Ressler KJ (2012) Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav 11, 503-512.
4. Apfel SC (2001) Neurotrophic factor therapy-prospects and problems. Clin Chem Lab Med 39, 351-355.
5. Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D, Langone F, Popoli M and Tongiorgi E (2012) Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 37, 1600-1611.
6. Barbacid M (1995) Structural and functional properties of the TRK family of neurotrophin receptors. Ann N Y Acad Sci 766, 442-458.
7. Barde YA (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 390, 45-56.
8. Cottingham C, Jones A and Wang Q (2012) Desipramine selectively potentiates norepinephrine-elicited ERK1/2 activation through the α2A adrenergic receptor. Biochem Biophys Res Commun 420, 161-165.
9. Duman RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7, S29-34.
10. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5, 11-25.
11. Duman RS and Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59, 1116-1127.
12. Furukawa S (2009) Development of therapeutic drugs for depression and Alzheimer's disease. Chemical Engineering (in Japanese) 54, 18-24.
13. Gould E and Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiatry 46, 1472-1479.
14. Gould E, Tanapat P, McEwen BS, Flugge G and Fuchs E (1998) Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 95, 3168-3171.
15. Hirakawa A, Shimizu K, Fukumitsu H, Soumiya H, Iinuma M and Furukawa S (2010) 2-Decenoic acid ethyl ester, a derivative of unsaturated medium-chain fatty acids, facilitates functional recovery of locomotor activity after spinal cord injury. Neuroscience 171, 1377-1385.
16. Huang EJ and Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24, 677-736.
17. Ito N, Nagai T, Yabe T, Nunome S, Hanawa T and Yamada H (2006) Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis. Phytomedicine 13, 658-667.
18. Jang SW, Liu X, Chan CB, France SA, Sayeed I, Tang W, Lin X, Xiao G, Andero R, Chang Q, Ressler KJ and Ye K (2010) Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS One 5, e11528.
19. Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE and Ye K (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA 107, 2687-2692.
20. Kaplan DR and Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10, 381-391.
21. Karpova NN, Pickenhagen A, Lindholm J, Tiraboschi E, Kulesskaya N, Agústsdóttir A, Antila H, Popova D, Akamine Y, Bahi A, Sullivan R, Hen R, Drew LJ and Castrén E (2011) Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 334, 1731-1734.
22. Kasai M, Fukumitsu H, Soumiya H and Furukawa S (2010) Ethanol extract of chinese propolis facilitates functional recovery of locomotor activity after spinal cord injury. Evid Based Complement Alternat Med 2011. pii. 749627. Epub.2010, Sep. 8.
23. Kirtley A and Thomas KL (2010) The exclusive induction of extinction is gated by BDNF. Learn Mem 17, 612-619.
24. Kitayama N, Vaccarino V, Kutner M, Weiss P and Bremner JD (2005) Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord 88, 79-86.
25. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T, Kunz D and Gallinat J (2005) Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180, 95-99.
26. Lattal KM, Barrett RM and Wood MA (2007) Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 121, 1125-1131.
27. Lo DC (1995) Neurotrophic factors and synaptic plasticity. Neuron 15, 979-981.
28. Lu B (2003) BDNF and activity-dependent synaptic modulation. Learn Mem 10, 86-98.
29. Makino A, Iinuma M, Fukumitsu H, Soumiya H, Furukawa Y and Furukawa S (2010) 2-Decenoic acid ethyl ester possesses neurotrophin-like activities to facilitate intracellular signals and increase synapse-specific proteins in neurons cultured from embryonic rat brain. Biomed Res 31, 379-386.
30. Sheline YI, Gado MH and Kraemer HC (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry 160, 1516-1518.
31. Siuciak JA, Lewis DR, Wiegand SJ and Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56, 131-137.
32. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S and Senba E (1997) Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28, 103-110.
33. Vale AL, Green S, Montgomery AM and Shafi S (1998) The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test. J Psychopharmacol 12, 268-272.